Research on TIM-3 Alzheimer's treatment is opening new doors in the fight against Alzheimer’s disease, showing promise in improving cognitive function and amyloid beta clearance in affected patients.Recent findings highlight how inhibiting TIM-3, an immune checkpoint molecule, can unleash microglia—the brain's immune cells—to effectively clear harmful plaques associated with Alzheimer's.